Found: 6
Select item for more details and to access through your institution.
Clinical characteristics and outcomes of adult alveolar rhabdomyosarcoma patients on first-line systemic therapies: A single-institution cohort.
- Published in:
- Rare Tumors, 2024, p. 1, doi. 10.1177/20363613241271669
- By:
- Publication type:
- Article
Utility of Clinical Next Generation Sequencing Tests in KIT/PDGFRA/SDH Wild-Type Gastrointestinal Stromal Tumors.
- Published in:
- Cancers, 2024, v. 16, n. 9, p. 1707, doi. 10.3390/cancers16091707
- By:
- Publication type:
- Article
Outcomes of Late-Line Systemic Treatment in GIST: Does Sequence Matter?
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 904, doi. 10.3390/cancers16050904
- By:
- Publication type:
- Article
The Future of Targeted Therapy for Leiomyosarcoma.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 938, doi. 10.3390/cancers16050938
- By:
- Publication type:
- Article
Epigenetic re-expression of HIF-2α suppresses soft tissue sarcoma growth.
- Published in:
- Nature Communications, 2016, v. 7, n. 2, p. 10539, doi. 10.1038/ncomms10539
- By:
- Publication type:
- Article
Overcoming evasive resistance from vascular endothelial growth factor a inhibition in sarcomas by genetic or pharmacologic targeting of hypoxia-inducible factor 1α.
- Published in:
- International Journal of Cancer, 2013, v. 132, n. 1, p. 29, doi. 10.1002/ijc.27666
- By:
- Publication type:
- Article